Chantix (varenicline) is the latest option for smoking cessation

August 2006

Chantix (varenicline) is the latest option for smoking cessation.

It's the first PARTIAL nicotine agonist. It binds to nicotine receptors...but stimulates them less than nicotine.

This partial nicotine effect helps ease withdrawal symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

the risk of jaw bone damage while taking Fosamax or other bisphosphonates
Cardiology reimbursement for Zocor and the new generic simvastatins
Cardiology More patients will be started on a beta-blocker before surgery
Vaccines CDC will soon recommend a booster of the chickenpox vaccine
Vaccines shortage of Menactra (meningococcal vaccine)
Neurology & Pain two new ORAL forms of oxymorphone called Opana and Opana ER
Diabetes New "guidelines" for treating pain due to diabetic peripheral neuropathy
Infectious Diseases several changes in HIV drug therapy
Women's Health new oral contraceptive called Seasonique
Women's Health prenatal vitamins with DHA
treatment options for eating disorders
Hematology & Oncology Sprycel (dasatinib), a new oral drug for certain forms of leukemia
Hematology & Oncology Cesamet (nabilone) is a new option for nausea and vomiting associated with chemotherapy
Smoking Cessation Chantix (varenicline) is the latest option for smoking cessation